Deep Track Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
15
- Investments
-
76
- Portfolio
-
39
- Exits
-
26
Deep Track Capital General Information
Company Description
Founded in 2020, Deep Track Capital is a venture capital investment firm based in Greenwich, Connecticut. The firm seeks to invest in companies operating in the biotechnology and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.deeptrackcapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 200 Greenwich Avenue
- 3rd Floor
- Greenwich, CT 06830
- United States
Deep Track Capital Investments (76)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Attovia | 15-Apr-2025 | Later Stage VC | Biotechnology | Clinical Trials - Phase 1 | ||
| Imbria Pharmaceuticals | 10-Apr-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Arbor Biotechnologies | 18-Mar-2025 | Biotechnology | Generating Revenue | |||
| Latigo Bio | 17-Mar-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Tectonic Therapeutic | 03-Feb-2025 | Drug Discovery | Generating Revenue | |||
| RAPT Therapeutics | 27-Dec-2024 | Drug Discovery | Generating Revenue | |||
| Inmagene | 23-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Maze Therapeutics | 26-Nov-2024 | Drug Discovery | Profitable | |||
| 35Pharma | 22-Nov-2024 | Later Stage VC | Biotechnology | Clinical Trials - General | ||
| Metsera | 13-Nov-2024 | Early Stage VC | Drug Discovery | Generating Revenue/Not Profitable |
Deep Track Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Maze Therapeutics | 31-Jan-2025 | IPO | |
| Metsera | 31-Jan-2025 | ||
| Spyre Therapeutics | 19-Nov-2024 | ||
| Septerna | 25-Oct-2024 | ||
| OnKure Therapeutics | 04-Oct-2024 | ||
| MBX Biosciences | 13-Sep-2024 | ||
| Viridian Therapeutics | 13-Sep-2024 | ||
| Structure Therapeutics | 06-Jun-2024 | ||
| Regulus Therapeutics | 09-May-2024 | Public Investment 2nd Offering | |
| Metagenomi | 09-Feb-2024 | IPO |
Deep Track Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Deep Track Capital Co-Investors (214)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 17 |
|
|
||
| Janus Henderson Investors |
|
|
|||
| Surveyor Capital |
|
|
|||
| Logos Capital |
|
|
|||
| Frazier Healthcare Partners |
|
|
Deep Track Capital FAQs
-
What is Deep Track Capital?
Founded in 2020, Deep Track Capital is a venture capital investment firm based in Greenwich, Connecticut.
-
When was Deep Track Capital founded?
Deep Track Capital was founded in 2020.
-
Where is Deep Track Capital headquartered?
Deep Track Capital is headquartered in Greenwich, CT.
-
What is Deep Track Capital's total asset value?
Deep Track Capital has around in total assets under management.
-
How many investments has Deep Track Capital made?
Deep Track Capital has made 76 investments.
-
What has Deep Track Capital invested in?
Deep Track Capital has made numerous investments in companies like Attovia, Imbria Pharmaceuticals, and Arbor Biotechnologies within the Biotechnology and Drug Discovery industries.
-
What has Deep Track Capital invested in recently?
Deep Track Capital's latest investment was on 15-Apr-2025 in Attovia, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
